J. Spic k / J.L. Boyer / T. Gilat / J. Kotrlik / Z. Marecek / G. Paumgartner (Hgg.)New Aspects and Clinical Implications
Diseases of the Liver and the Bile Ducts
New Aspects and Clinical Implications
Herausgegeben:Spicák, J.; Boyer, J. L.; Gilat, T.; Kotrlik, J.; Marecek, Z.; Paumgartner, G.
J. Spic k / J.L. Boyer / T. Gilat / J. Kotrlik / Z. Marecek / G. Paumgartner (Hgg.)New Aspects and Clinical Implications
Diseases of the Liver and the Bile Ducts
New Aspects and Clinical Implications
Herausgegeben:Spicák, J.; Boyer, J. L.; Gilat, T.; Kotrlik, J.; Marecek, Z.; Paumgartner, G.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
In recent years, knowledge about the cell biology of the cholangiocytes and the function of the bile ducts has increased considerably. Their role in liver diseases is increasingly recognized. As a consequence, important progress has been made not only in the pathogenesis and pathophysiology but also in the diagnosis and treatment of biliary liver diseases. This book, the proceedings of the Falk Symposium 107 on `Diseases of the Liver and the Bile Ducts - New Aspects and Clinical Implications', held in Prague, Czech Republic, on April 30-May 2, 1998, brings together scientists and clinicians to…mehr
Andere Kunden interessierten sich auch für
- PaumgartnerBile Acids and Hepatobiliary Diseases - Basic Research and Clinical Application153,99 €
- G. Paumgartner / U. Beuers (eds.)Bile Acids in Liver Diseases115,99 €
- van Berge HenegouwenBiology of Bile Acids in Health and Disease115,99 €
- PaumgartnerEnterohepatic Circulation of Bile Acids and Sterol Metabolism153,99 €
- Diseases of the Liver and Bile Ducts82,99 €
- NorthfieldBile Acids in Hepatobiliary Disease115,99 €
- George Y. Wu (ed.)Diseases of the Liver and Bile Ducts164,99 €
-
-
-
In recent years, knowledge about the cell biology of the cholangiocytes and the function of the bile ducts has increased considerably. Their role in liver diseases is increasingly recognized. As a consequence, important progress has been made not only in the pathogenesis and pathophysiology but also in the diagnosis and treatment of biliary liver diseases. This book, the proceedings of the Falk Symposium 107 on `Diseases of the Liver and the Bile Ducts - New Aspects and Clinical Implications', held in Prague, Czech Republic, on April 30-May 2, 1998, brings together scientists and clinicians to highlight the most recent advances in molecular biology, physiology, diagnosis and therapy of diseases of the biliary system. World experts cover a broad spectrum of topics from genetic tests to endoscopy and from medical treatment to liver transplantation.
Produktdetails
- Produktdetails
- Falk Symposium 107
- Verlag: Springer / Springer Netherlands
- Artikelnr. des Verlages: 978-0-7923-8751-0
- 1999.
- Seitenzahl: 268
- Erscheinungstermin: 31. Mai 1999
- Englisch
- Abmessung: 241mm x 160mm x 20mm
- Gewicht: 553g
- ISBN-13: 9780792387510
- ISBN-10: 0792387511
- Artikelnr.: 23080620
- Herstellerkennzeichnung
- Springer-Verlag GmbH
- Tiergartenstr. 17
- 69121 Heidelberg
- ProductSafety@springernature.com
- Falk Symposium 107
- Verlag: Springer / Springer Netherlands
- Artikelnr. des Verlages: 978-0-7923-8751-0
- 1999.
- Seitenzahl: 268
- Erscheinungstermin: 31. Mai 1999
- Englisch
- Abmessung: 241mm x 160mm x 20mm
- Gewicht: 553g
- ISBN-13: 9780792387510
- ISBN-10: 0792387511
- Artikelnr.: 23080620
- Herstellerkennzeichnung
- Springer-Verlag GmbH
- Tiergartenstr. 17
- 69121 Heidelberg
- ProductSafety@springernature.com
List of Principal Authors. Preface. Section I: Morphology, Histopathology
and Oncology. 1. Proliferation and Ductal Morphogenesis of Bile Duct
Epithelial Cells; A.E. Sirica, et al. 2. Bile Duct Histopathology in Liver
Diseases; V.J. Desmet, et al. 3. Stem Cell Biology and Bile Ducts; S.S.
Thorgeirsson. 4. Cholangiocarcinoma - Clinical Aspects; K. Okuda. Section
II: Physiology and Molecular Biology of Bile Formation and Cholestatic
Liver Diseases. 5. Cholangiocyte physiology - Role in Bile Formation; J.G.
Fitz. 6. Cholangiocyte Dysfunction, Role in Cholestasis; M. Strazzabosco,
et al. 7. Dysregulation of Cholangiocyte Apoptosis by Cytokines; T. Patel.
8. MDR3 Deficiency and Progressive Familial Intrahepatic Cholestasis; E.
Jacquemin, et al. 9. Clinical Spectrum of Liver Disease in CFTR Deficiency
and Cystic Fibrosis; C. Colombo. 10. Cholestasis in Systemic Infection; M.
Trauner, et al. Section III: Cholestatic Liver Disesases - Autoimmunity.
11. Aetiopathogenesis and Clinical Spectrum of Primary Biliary Cirrhosis;
R.W. Chapman. 12. Pathogenesis and Clinical Spectrum of Primary Sclerosing
Cholangitis; U. Beuers, G. Paumgartner. 13. Immunopathogenesis of Primary
Biliary Cirrhosis: Contemporary Issues; L. Dubel, et al. 14. Structural
Features of Bile Ducts in Cholestatic Liver Diseases; A.M. Jezequel, et al.
Section IV: Cholestatic Liver Diseases - Drugs, Toxins, Fibrosis and
Gallstones. 15. Drug and Toxin Induced Vanishing Bile Duct Disorders; A.P.
Geubel, C. Sempoux. 16. Fibrosis and Bile Duct Injury; S.L. Friedman. 17.
The Pathogenesis of Gallstone Disease; Z. Mareček, et al. Section V:
From Genetics to Endoscopy. 18. Progressive Familial Intrahepatic
Cholestasis; P.L.M. Jansen, M. Müller. 19. Magnetic Resonance
Cholangiography in Diseases of the Bile Ducts; N. Holzknecht, M. Reiser.
20. Endoscopic Ultrasonography of the Biliary System; T. Rösch. 21.
Serological Tests in Cholestatic Liver Disorders: PSC, PBC, and Autoimmune
Cholangiopathy; C.P. Strassburg, M.P. Manns. Section VI: Chronic
Cholestatic Liver Diseases. 22. The Treatment of PBC and other Vanishing
Bile Duct Syndromes; J. Heathcote. 23. Management of Patients with Primary
Sclerosing Cholangitis: Medical, Interventional; A. Stiehl, et al. 24.
Therapeutic Approaches to Complications of Cholestasis; U. Leuschner. 25.
Liver Transplantation in Patients with Chronic Cholestatic Liver Diseases
&endash; Approaches to Detection of Rejection and its Treatment; M. Hertl,
et al. Section VII: Bile Duct Disorders and Gallstone Disease. 26. Biliary
Complications after Liver Transplantation: Diagnosis and Management; J.
Špičák. 28. Treatment of Gallstone Disease; S.M. Strasberg. Index.
and Oncology. 1. Proliferation and Ductal Morphogenesis of Bile Duct
Epithelial Cells; A.E. Sirica, et al. 2. Bile Duct Histopathology in Liver
Diseases; V.J. Desmet, et al. 3. Stem Cell Biology and Bile Ducts; S.S.
Thorgeirsson. 4. Cholangiocarcinoma - Clinical Aspects; K. Okuda. Section
II: Physiology and Molecular Biology of Bile Formation and Cholestatic
Liver Diseases. 5. Cholangiocyte physiology - Role in Bile Formation; J.G.
Fitz. 6. Cholangiocyte Dysfunction, Role in Cholestasis; M. Strazzabosco,
et al. 7. Dysregulation of Cholangiocyte Apoptosis by Cytokines; T. Patel.
8. MDR3 Deficiency and Progressive Familial Intrahepatic Cholestasis; E.
Jacquemin, et al. 9. Clinical Spectrum of Liver Disease in CFTR Deficiency
and Cystic Fibrosis; C. Colombo. 10. Cholestasis in Systemic Infection; M.
Trauner, et al. Section III: Cholestatic Liver Disesases - Autoimmunity.
11. Aetiopathogenesis and Clinical Spectrum of Primary Biliary Cirrhosis;
R.W. Chapman. 12. Pathogenesis and Clinical Spectrum of Primary Sclerosing
Cholangitis; U. Beuers, G. Paumgartner. 13. Immunopathogenesis of Primary
Biliary Cirrhosis: Contemporary Issues; L. Dubel, et al. 14. Structural
Features of Bile Ducts in Cholestatic Liver Diseases; A.M. Jezequel, et al.
Section IV: Cholestatic Liver Diseases - Drugs, Toxins, Fibrosis and
Gallstones. 15. Drug and Toxin Induced Vanishing Bile Duct Disorders; A.P.
Geubel, C. Sempoux. 16. Fibrosis and Bile Duct Injury; S.L. Friedman. 17.
The Pathogenesis of Gallstone Disease; Z. Mareček, et al. Section V:
From Genetics to Endoscopy. 18. Progressive Familial Intrahepatic
Cholestasis; P.L.M. Jansen, M. Müller. 19. Magnetic Resonance
Cholangiography in Diseases of the Bile Ducts; N. Holzknecht, M. Reiser.
20. Endoscopic Ultrasonography of the Biliary System; T. Rösch. 21.
Serological Tests in Cholestatic Liver Disorders: PSC, PBC, and Autoimmune
Cholangiopathy; C.P. Strassburg, M.P. Manns. Section VI: Chronic
Cholestatic Liver Diseases. 22. The Treatment of PBC and other Vanishing
Bile Duct Syndromes; J. Heathcote. 23. Management of Patients with Primary
Sclerosing Cholangitis: Medical, Interventional; A. Stiehl, et al. 24.
Therapeutic Approaches to Complications of Cholestasis; U. Leuschner. 25.
Liver Transplantation in Patients with Chronic Cholestatic Liver Diseases
&endash; Approaches to Detection of Rejection and its Treatment; M. Hertl,
et al. Section VII: Bile Duct Disorders and Gallstone Disease. 26. Biliary
Complications after Liver Transplantation: Diagnosis and Management; J.
Špičák. 28. Treatment of Gallstone Disease; S.M. Strasberg. Index.
List of Principal Authors. Preface. Section I: Morphology, Histopathology
and Oncology. 1. Proliferation and Ductal Morphogenesis of Bile Duct
Epithelial Cells; A.E. Sirica, et al. 2. Bile Duct Histopathology in Liver
Diseases; V.J. Desmet, et al. 3. Stem Cell Biology and Bile Ducts; S.S.
Thorgeirsson. 4. Cholangiocarcinoma - Clinical Aspects; K. Okuda. Section
II: Physiology and Molecular Biology of Bile Formation and Cholestatic
Liver Diseases. 5. Cholangiocyte physiology - Role in Bile Formation; J.G.
Fitz. 6. Cholangiocyte Dysfunction, Role in Cholestasis; M. Strazzabosco,
et al. 7. Dysregulation of Cholangiocyte Apoptosis by Cytokines; T. Patel.
8. MDR3 Deficiency and Progressive Familial Intrahepatic Cholestasis; E.
Jacquemin, et al. 9. Clinical Spectrum of Liver Disease in CFTR Deficiency
and Cystic Fibrosis; C. Colombo. 10. Cholestasis in Systemic Infection; M.
Trauner, et al. Section III: Cholestatic Liver Disesases - Autoimmunity.
11. Aetiopathogenesis and Clinical Spectrum of Primary Biliary Cirrhosis;
R.W. Chapman. 12. Pathogenesis and Clinical Spectrum of Primary Sclerosing
Cholangitis; U. Beuers, G. Paumgartner. 13. Immunopathogenesis of Primary
Biliary Cirrhosis: Contemporary Issues; L. Dubel, et al. 14. Structural
Features of Bile Ducts in Cholestatic Liver Diseases; A.M. Jezequel, et al.
Section IV: Cholestatic Liver Diseases - Drugs, Toxins, Fibrosis and
Gallstones. 15. Drug and Toxin Induced Vanishing Bile Duct Disorders; A.P.
Geubel, C. Sempoux. 16. Fibrosis and Bile Duct Injury; S.L. Friedman. 17.
The Pathogenesis of Gallstone Disease; Z. Mareček, et al. Section V:
From Genetics to Endoscopy. 18. Progressive Familial Intrahepatic
Cholestasis; P.L.M. Jansen, M. Müller. 19. Magnetic Resonance
Cholangiography in Diseases of the Bile Ducts; N. Holzknecht, M. Reiser.
20. Endoscopic Ultrasonography of the Biliary System; T. Rösch. 21.
Serological Tests in Cholestatic Liver Disorders: PSC, PBC, and Autoimmune
Cholangiopathy; C.P. Strassburg, M.P. Manns. Section VI: Chronic
Cholestatic Liver Diseases. 22. The Treatment of PBC and other Vanishing
Bile Duct Syndromes; J. Heathcote. 23. Management of Patients with Primary
Sclerosing Cholangitis: Medical, Interventional; A. Stiehl, et al. 24.
Therapeutic Approaches to Complications of Cholestasis; U. Leuschner. 25.
Liver Transplantation in Patients with Chronic Cholestatic Liver Diseases
&endash; Approaches to Detection of Rejection and its Treatment; M. Hertl,
et al. Section VII: Bile Duct Disorders and Gallstone Disease. 26. Biliary
Complications after Liver Transplantation: Diagnosis and Management; J.
Špičák. 28. Treatment of Gallstone Disease; S.M. Strasberg. Index.
and Oncology. 1. Proliferation and Ductal Morphogenesis of Bile Duct
Epithelial Cells; A.E. Sirica, et al. 2. Bile Duct Histopathology in Liver
Diseases; V.J. Desmet, et al. 3. Stem Cell Biology and Bile Ducts; S.S.
Thorgeirsson. 4. Cholangiocarcinoma - Clinical Aspects; K. Okuda. Section
II: Physiology and Molecular Biology of Bile Formation and Cholestatic
Liver Diseases. 5. Cholangiocyte physiology - Role in Bile Formation; J.G.
Fitz. 6. Cholangiocyte Dysfunction, Role in Cholestasis; M. Strazzabosco,
et al. 7. Dysregulation of Cholangiocyte Apoptosis by Cytokines; T. Patel.
8. MDR3 Deficiency and Progressive Familial Intrahepatic Cholestasis; E.
Jacquemin, et al. 9. Clinical Spectrum of Liver Disease in CFTR Deficiency
and Cystic Fibrosis; C. Colombo. 10. Cholestasis in Systemic Infection; M.
Trauner, et al. Section III: Cholestatic Liver Disesases - Autoimmunity.
11. Aetiopathogenesis and Clinical Spectrum of Primary Biliary Cirrhosis;
R.W. Chapman. 12. Pathogenesis and Clinical Spectrum of Primary Sclerosing
Cholangitis; U. Beuers, G. Paumgartner. 13. Immunopathogenesis of Primary
Biliary Cirrhosis: Contemporary Issues; L. Dubel, et al. 14. Structural
Features of Bile Ducts in Cholestatic Liver Diseases; A.M. Jezequel, et al.
Section IV: Cholestatic Liver Diseases - Drugs, Toxins, Fibrosis and
Gallstones. 15. Drug and Toxin Induced Vanishing Bile Duct Disorders; A.P.
Geubel, C. Sempoux. 16. Fibrosis and Bile Duct Injury; S.L. Friedman. 17.
The Pathogenesis of Gallstone Disease; Z. Mareček, et al. Section V:
From Genetics to Endoscopy. 18. Progressive Familial Intrahepatic
Cholestasis; P.L.M. Jansen, M. Müller. 19. Magnetic Resonance
Cholangiography in Diseases of the Bile Ducts; N. Holzknecht, M. Reiser.
20. Endoscopic Ultrasonography of the Biliary System; T. Rösch. 21.
Serological Tests in Cholestatic Liver Disorders: PSC, PBC, and Autoimmune
Cholangiopathy; C.P. Strassburg, M.P. Manns. Section VI: Chronic
Cholestatic Liver Diseases. 22. The Treatment of PBC and other Vanishing
Bile Duct Syndromes; J. Heathcote. 23. Management of Patients with Primary
Sclerosing Cholangitis: Medical, Interventional; A. Stiehl, et al. 24.
Therapeutic Approaches to Complications of Cholestasis; U. Leuschner. 25.
Liver Transplantation in Patients with Chronic Cholestatic Liver Diseases
&endash; Approaches to Detection of Rejection and its Treatment; M. Hertl,
et al. Section VII: Bile Duct Disorders and Gallstone Disease. 26. Biliary
Complications after Liver Transplantation: Diagnosis and Management; J.
Špičák. 28. Treatment of Gallstone Disease; S.M. Strasberg. Index.